Quantitative online prediction of peptide binding to the major histocompatibility complex.
暂无分享,去创建一个
Channa K. Hattotuwagama | Pingping Guan | Christianna Zygouri | Darren R Flower | Irini A Doytchinova | D. Flower | I. Doytchinova | P. Guan | C. Zygouri | Channa K Hattotuwagama
[1] Irini Doytchinova,et al. The HLA-A2-supermotif: a QSAR definition. , 2003, Organic & biomolecular chemistry.
[2] D. Flower,et al. Physicochemical explanation of peptide binding to HLA‐A*0201 major histocompatibility complex: A three‐dimensional quantitative structure‐activity relationship study , 2002, Proteins.
[3] F. Sinigaglia,et al. Motifs and supermotifs for MHC class II binding peptides , 1995, The Journal of experimental medicine.
[4] K. Parker,et al. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.
[5] M. Reddehase,et al. Two Antigenic Peptides from Genes m123 and m164 of Murine Cytomegalovirus Quantitatively Dominate CD8 T-Cell Memory in the H-2d Haplotype , 2002, Journal of Virology.
[6] Gajendra P. S. Raghava,et al. ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..
[7] H. Grey,et al. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[8] W R Taylor,et al. Location of ‘continuous’ antigenic determinants in the protruding regions of proteins. , 1986, The EMBO journal.
[9] Pingping Guan,et al. HLA-A3 supermotif defined by quantitative structure-activity relationship analysis. , 2003, Protein engineering.
[10] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[11] S. Wold,et al. Peptide quantitative structure-activity relationships, a multivariate approach. , 1987, Journal of medicinal chemistry.
[12] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.
[13] A. Tropsha,et al. Beware of q2! , 2002, Journal of molecular graphics & modelling.
[14] J. Sidney,et al. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.
[15] Bruce L. Bush,et al. Sample-distance partial least squares: PLS optimized for many variables, with application to CoMFA , 1993, J. Comput. Aided Mol. Des..
[16] J. Drijfhout,et al. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. , 1995, Human immunology.
[17] L. Zhihua,et al. Toward the quantitative prediction of T-cell epitopes: QSAR studies on peptides having affinity with the class I MHC molecular HLA-A*0201. , 2004, Journal of computational biology : a journal of computational molecular cell biology.
[18] S. Wold,et al. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. , 1998, Journal of medicinal chemistry.
[19] D. Flower,et al. Additive method for the prediction of protein-peptide binding affinity. Application to the MHC class I molecule HLA-A*0201. , 2002, Journal of proteome research.
[20] W. Saenger,et al. Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus. , 1998, Journal of molecular biology.
[21] D. Flower,et al. Toward the quantitative prediction of T-cell epitopes: coMFA and coMSIA studies of peptides with affinity for the class I MHC molecule HLA-A*0201. , 2001, Journal of medicinal chemistry.
[22] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[23] M F del Guercio,et al. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. , 1996, Journal of immunology.
[24] A. Alix,et al. Predictive estimation of protein linear epitopes by using the program PEOPLE. , 1999, Vaccine.
[25] E Westhof,et al. PREDITOP: a program for antigenicity prediction. , 1993, Journal of molecular graphics.
[26] R W Chesnut,et al. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. , 1997, The Journal of clinical investigation.
[27] M. Reddehase,et al. Early gene m18, a novel player in the immune response to murine cytomegalovirus. , 2002, The Journal of general virology.
[28] S Ferrone,et al. HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. , 1994, International immunology.
[29] Irini A. Doytchinova,et al. JenPep: a database of quantitative functional peptide data for immunology , 2002, Bioinform..
[30] D I Stuart,et al. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. , 1996, Immunity.
[31] H. Rammensee,et al. SYFPEITHI: database for MHC ligands and peptide motifs , 1999, Immunogenetics.
[32] Steven A. Rosenberg,et al. Identification of a MHC Class II-Restricted Human gp100 Epitope Using DR4-IE Transgenic Mice , 2000, The Journal of Immunology.
[33] G. Jung,et al. From combinatorial libraries to MHC ligand motifs, T-cell superagonists and antagonists. , 2001, Biologicals : journal of the International Association of Biological Standardization.
[34] John Sidney,et al. Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide , 2001, The Journal of experimental medicine.
[35] Martin T. Swain,et al. An automated approach to modelling class II MHC alleles and predicting peptide binding , 2001, Proceedings 2nd Annual IEEE International Symposium on Bioinformatics and Bioengineering (BIBE 2001).
[36] Irini A. Doytchinova,et al. Computational vaccine design , 2002 .
[37] R W Chesnut,et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.